The global biotechnology contract manufacturing market size is accounted at USD 22.93 billion in 2025 and is forecasted to hit around USD 49.06 billion by 2034, representing a CAGR of 8.82% from 2025 to 2034. The North America market size was estimated at USD 7.16 billion in 2024 and is expanding at a CAGR of 8.98% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biotechnology Contract Manufacturing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biotechnology Contract Manufacturing Market, by Service
8.1.1. Manufacturing
8.1.1.1. Market Revenue and Forecast
8.1.2. Formulation and Fill-Finish
8.1.2.1. Market Revenue and Forecast
8.1.3. Packaging and Labeling
8.1.3.1. Market Revenue and Forecast
8.1.4. Other services
8.1.4.1. Market Revenue and Forecast
9.1. Biotechnology Contract Manufacturing Market, by Type
9.1.1. Biologic Drug Substance Manufacturing
9.1.1.1. Market Revenue and Forecast
9.1.2. Biologic Drug Product Manufacturing
9.1.2.1. Market Revenue and Forecast
10.1. Biotechnology Contract Manufacturing Market, by Scale
10.1.1. Commercial Operations
10.1.1.1. Market Revenue and Forecast
10.1.2. Clinical Operations
10.1.2.1. Market Revenue and Forecast
11.1. Biotechnology Contract Manufacturing Market, by Source
11.1.1. Mammalian Expression Systems
11.1.1.1. Market Revenue and Forecast
11.1.2. Non-Mammalian Expression Systems
11.1.2.1. Market Revenue and Forecast
12.1. Biotechnology Contract Manufacturing Market, by Molecule
12.1.1. Monoclonal Antibodies
12.1.1.1. Market Revenue and Forecast
12.1.2. Cell Therapy and Gene Therapy
12.1.2.1. Market Revenue and Forecast
12.1.3. Antibody-Drug Conjugates (ADCs)
12.1.3.1. Market Revenue and Forecast
12.1.4. Vaccines
12.1.4.1. Market Revenue and Forecast
12.1.5. Therapeutic Peptides and Proteins
12.1.5.1. Market Revenue and Forecast
12.1.6. Other Molecule Types
12.1.6.1. Market Revenue and Forecast
13.1. Biotechnology Contract Manufacturing Market, by Therapeutic Area
13.1.1. Oncology
13.1.1.1. Market Revenue and Forecast
13.1.2. Autoimmune Diseases
13.1.2.1. Market Revenue and Forecast
13.1.3. Cardiovascular Diseases
13.1.3.1. Market Revenue and Forecast
13.1.4. Metabolic Diseases
13.1.4.1. Market Revenue and Forecast
13.1.5. Infectious Diseases
13.1.5.1. Market Revenue and Forecast
13.1.6. Neurology
13.1.6.1. Market Revenue and Forecast
13.1.7. Other Therapeutic Areas
13.1.7.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Service
14.1.2. Market Revenue and Forecast, by Type
14.1.3. Market Revenue and Forecast, by Scale
14.1.4. Market Revenue and Forecast, by Source
14.1.5. Market Revenue and Forecast, by Molecule
14.1.6. Market Revenue and Forecast, by Therapeutic Area
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Service
14.1.7.2. Market Revenue and Forecast, by Type
14.1.7.3. Market Revenue and Forecast, by Scale
14.1.7.4. Market Revenue and Forecast, by Source
14.1.8. Market Revenue and Forecast, by Molecule
14.1.8.1. Market Revenue and Forecast, by Therapeutic Area
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Service
14.1.9.2. Market Revenue and Forecast, by Type
14.1.9.3. Market Revenue and Forecast, by Scale
14.1.9.4. Market Revenue and Forecast, by Source
14.1.10. Market Revenue and Forecast, by Molecule
14.1.11. Market Revenue and Forecast, by Therapeutic Area
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Service
14.2.2. Market Revenue and Forecast, by Type
14.2.3. Market Revenue and Forecast, by Scale
14.2.4. Market Revenue and Forecast, by Source
14.2.5. Market Revenue and Forecast, by Molecule
14.2.6. Market Revenue and Forecast, by Therapeutic Area
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Service
14.2.8.2. Market Revenue and Forecast, by Type
14.2.8.3. Market Revenue and Forecast, by Scale
14.2.9. Market Revenue and Forecast, by Source
14.2.10. Market Revenue and Forecast, by Molecule
14.2.10.1. Market Revenue and Forecast, by Therapeutic Area
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Service
14.2.11.2. Market Revenue and Forecast, by Type
14.2.11.3. Market Revenue and Forecast, by Scale
14.2.12. Market Revenue and Forecast, by Source
14.2.13. Market Revenue and Forecast, by Molecule
14.2.14. Market Revenue and Forecast, by Therapeutic Area
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Service
14.2.15.2. Market Revenue and Forecast, by Type
14.2.15.3. Market Revenue and Forecast, by Scale
14.2.15.4. Market Revenue and Forecast, by Source
14.2.16. Market Revenue and Forecast, by Molecule
14.2.16.1. Market Revenue and Forecast, by Therapeutic Area
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Service
14.2.17.2. Market Revenue and Forecast, by Type
14.2.17.3. Market Revenue and Forecast, by Scale
14.2.17.4. Market Revenue and Forecast, by Source
14.2.18. Market Revenue and Forecast, by Molecule
14.2.18.1. Market Revenue and Forecast, by Therapeutic Area
14.3. APAC
14.3.1. Market Revenue and Forecast, by Service
14.3.2. Market Revenue and Forecast, by Type
14.3.3. Market Revenue and Forecast, by Scale
14.3.4. Market Revenue and Forecast, by Source
14.3.5. Market Revenue and Forecast, by Molecule
14.3.6. Market Revenue and Forecast, by Therapeutic Area
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Service
14.3.7.2. Market Revenue and Forecast, by Type
14.3.7.3. Market Revenue and Forecast, by Scale
14.3.7.4. Market Revenue and Forecast, by Source
14.3.8. Market Revenue and Forecast, by Molecule
14.3.9. Market Revenue and Forecast, by Therapeutic Area
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Service
14.3.10.2. Market Revenue and Forecast, by Type
14.3.10.3. Market Revenue and Forecast, by Scale
14.3.10.4. Market Revenue and Forecast, by Source
14.3.11. Market Revenue and Forecast, by Molecule
14.3.11.1. Market Revenue and Forecast, by Therapeutic Area
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Service
14.3.12.2. Market Revenue and Forecast, by Type
14.3.12.3. Market Revenue and Forecast, by Scale
14.3.12.4. Market Revenue and Forecast, by Source
14.3.12.5. Market Revenue and Forecast, by Molecule
14.3.12.6. Market Revenue and Forecast, by Therapeutic Area
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Service
14.3.13.2. Market Revenue and Forecast, by Type
14.3.13.3. Market Revenue and Forecast, by Scale
14.3.13.4. Market Revenue and Forecast, by Source
14.3.13.5. Market Revenue and Forecast, by Molecule
14.3.13.6. Market Revenue and Forecast, by Therapeutic Area
14.4. MEA
14.4.1. Market Revenue and Forecast, by Service
14.4.2. Market Revenue and Forecast, by Type
14.4.3. Market Revenue and Forecast, by Scale
14.4.4. Market Revenue and Forecast, by Source
14.4.5. Market Revenue and Forecast, by Molecule
14.4.6. Market Revenue and Forecast, by Therapeutic Area
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Service
14.4.7.2. Market Revenue and Forecast, by Type
14.4.7.3. Market Revenue and Forecast, by Scale
14.4.7.4. Market Revenue and Forecast, by Source
14.4.8. Market Revenue and Forecast, by Molecule
14.4.9. Market Revenue and Forecast, by Therapeutic Area
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Service
14.4.10.2. Market Revenue and Forecast, by Type
14.4.10.3. Market Revenue and Forecast, by Scale
14.4.10.4. Market Revenue and Forecast, by Source
14.4.11. Market Revenue and Forecast, by Molecule
14.4.12. Market Revenue and Forecast, by Therapeutic Area
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Service
14.4.13.2. Market Revenue and Forecast, by Type
14.4.13.3. Market Revenue and Forecast, by Scale
14.4.13.4. Market Revenue and Forecast, by Source
14.4.13.5. Market Revenue and Forecast, by Molecule
14.4.13.6. Market Revenue and Forecast, by Therapeutic Area
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Service
14.4.14.2. Market Revenue and Forecast, by Type
14.4.14.3. Market Revenue and Forecast, by Scale
14.4.14.4. Market Revenue and Forecast, by Source
14.4.14.5. Market Revenue and Forecast, by Molecule
14.4.14.6. Market Revenue and Forecast, by Therapeutic Area
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Service
14.5.2. Market Revenue and Forecast, by Type
14.5.3. Market Revenue and Forecast, by Scale
14.5.4. Market Revenue and Forecast, by Source
14.5.5. Market Revenue and Forecast, by Molecule
14.5.6. Market Revenue and Forecast, by Therapeutic Area
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Service
14.5.7.2. Market Revenue and Forecast, by Type
14.5.7.3. Market Revenue and Forecast, by Scale
14.5.7.4. Market Revenue and Forecast, by Source
14.5.8. Market Revenue and Forecast, by Molecule
14.5.8.1. Market Revenue and Forecast, by Therapeutic Area
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Service
14.5.9.2. Market Revenue and Forecast, by Type
14.5.9.3. Market Revenue and Forecast, by Scale
14.5.9.4. Market Revenue and Forecast, by Source
14.5.9.5. Market Revenue and Forecast, by Molecule
14.5.9.6. Market Revenue and Forecast, by Therapeutic Area
15.1. Lonza
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Thermo Fisher Scientific, Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Catalent, Inc.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Samsung Biologics
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. WuXi Biologics
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Boehringer Ingelheim International GmbH
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. FUJIFILM Holding Corporation
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. AbbVie, Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Eurofins Scientific
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. AGC, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample